COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Enhancing Freshwater Fish Consumption in Algeria: A Study on the Nutritional and Sensory Attributes of Common Carp Sticks
- The Association Between Perceived Stress, Lifestyle and Dietary Behaviors, and Hypertension Among University Personnel
- Nutritional Status, Muscle Mass, and Body Fat Percentage in Patients with Breast Cancer Undergoing Adjuvant Chemotherapy
- Editorial introduction to the first issue
- An update of the nutritional situation in eastern Algeria
- Antioxidant activity and polyphenol composition of Pistacia terebinthus fruit from Tessala (Western Algeria)
- Prevalence and determinants of overweight and obesity among in-school adolescents in Harare, Zimbabwe
- Antibacterial and antihemolytic assessment of Allium sativum through optimized protein fraction extraction
- Effect of polysaccharide-coatings on the physicochemical properties and nutritional composition of deep-fried chicken breasts
- The Role of Barley, Sorghum, Rice, and Maize in North African Cuisine
You may also start an advanced similarity search for this article.
NAJFNR is licensed under